MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
13.74
-0.11 (-0.76%)
Sep 10, 2026, 4:00 PM EDT - Market closed
MediWound Revenue
MediWound had revenue of $3.09M in the quarter ending June 30, 2026, a decrease of -45.83%. This brings the company's revenue in the last twelve months to $11.86M, down -40.26% year-over-year. In the year 2025, MediWound had annual revenue of $16.96M, down -16.14%.
Revenue (ttm)
$11.86M
Revenue Growth
-40.26%
P/S Ratio
14.84
Revenue / Employee
$98,041
Employees
121
Market Cap
176.48M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.96M | -3.26M | -16.14% |
| Dec 31, 2024 | 20.22M | 1.54M | 8.22% |
| Dec 31, 2023 | 18.69M | -7.81M | -29.48% |
| Dec 31, 2022 | 26.50M | 2.73M | 11.50% |
| Dec 31, 2021 | 23.76M | 2.00M | 9.19% |
| Dec 31, 2020 | 21.76M | -10.03M | -31.54% |
| Dec 31, 2019 | 31.79M | 28.39M | 834.70% |
| Dec 31, 2018 | 3.40M | 905.00K | 36.26% |
| Dec 31, 2017 | 2.50M | 938.00K | 60.21% |
| Dec 31, 2016 | 1.56M | 957.00K | 159.23% |
| Dec 31, 2015 | 601.00K | 342.00K | 132.05% |
| Dec 31, 2014 | 259.00K | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| LENZ Therapeutics | 21.48M |
| Innate Pharma | 10.57M |
| Caribou Biosciences | 10.04M |
| Milestone Pharmaceuticals | 2.34M |
| Humacyte | 2.12M |
| Kazia Therapeutics | 1.27M |
| Molecular Partners AG | 856.30K |
| Spruce Biosciences | 697.00K |
MDWD News
- 8 days ago - MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 24 days ago - MediWound reports Q2 EPS ($1.36), consensus (77c) - TheFly
- 24 days ago - MediWound backs FY26 revenue view $24M-$26M, consensus $24.13M - TheFly
- 25 days ago - MediWound price target lowered to $30 from $32 at Oppenheimer - TheFly
- 4 weeks ago - MediWound Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - MediWound Earnings release: Q2 2026 - Filings
- 4 weeks ago - MediWound Slides: Corporate presentation - Filings
- 4 weeks ago - MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire